Yosuke Kameoka

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Vasculitis-associated aberrant apolipoprotein A2 = VAP2 and SDF-1α in Kawasaki disease patients with coronary artery lesion.

Vasculitis-associated aberrant apolipoprotein A2 = VAP2 and SDF-1α in Kawasaki disease patients with coronary artery lesion.

Journal: Microvascular research

Published: November 03, 2025

Dynamics of scFv-targeted VAP2 correlating with IL-16, MIF and IL-1Ra in ANCA-associated vasculitis.

Dynamics of scFv-targeted VAP2 correlating with IL-16, MIF and IL-1Ra in ANCA-associated vasculitis.

Journal: Microvascular research

Published: April 02, 2024

Enhanced efficacy of the novel recombinant clone VasSF in a mouse model of antineutrophil cytoplasmic antibody-associated vasculitis.

Enhanced efficacy of the novel recombinant clone VasSF in a mouse model of antineutrophil cytoplasmic antibody-associated vasculitis.

Journal: Clinical and experimental immunology

Published: October 06, 2023

Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease.

Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease.

Journal: Pediatric rheumatology online journal

Published: October 03, 2022

Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.

Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.

Journal: Autoimmunity

Published: September 04, 2019

Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis [Corrigendum].

Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis [Corrigendum].

Journal: Drug design, development and therapy

Published: April 12, 2019

Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis.

Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis.

Journal: Drug design, development and therapy

Published: February 22, 2019

The Rare Disease Bank of Japan: establishment, current status and future challenges.

The Rare Disease Bank of Japan: establishment, current status and future challenges.

Journal: Human cell

Published: December 17, 2017

Correction: Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation.

Correction: Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation.

Journal: PloS one

Published: June 23, 2015

Finding the factors of reduced genetic diversity on X chromosomes of Macaca fascicularis: male-driven evolution, demography, and natural selection.

Finding the factors of reduced genetic diversity on X chromosomes of Macaca fascicularis: male-driven evolution, demography, and natural selection.

Journal: Genetics

Published: September 13, 2013

Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizoribine.

Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizoribine.

Journal: Microbiology and immunology

Published: December 06, 2012

Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation.

Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation.

Journal: PloS one

Published: September 12, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026